Full Title: Pharmaceutical Anti-Counterfeiting Strategies: Protecting profits through operational security, new technologies and industry partnerships
Executive Summary
The counterfeiting of pharmaceutical products is a multi-billion dollar industry and pharmaceutical companies must take measures to protect their products and profits: counterfeiting was previously a problem limited to developing countries, but in recent years with the increase in parallel trading and Internet pharmacies, the industry has also thrived in industrialized nations such as the US and in the EU. Pharmaceutical Anti-Counterfeiting Strategies: Protecting profits through operational security, new technologies and industry partnerships, is a new report which provides a detailed analysis of actionable product protection strategies drawing heavily from case studies and a survey of industry leaders. Unlike other reports on counterfeit drugs that only tackle the issue of anti-counterfeiting technology, this report also covers essential strategies involving internal organization, supply chain management, and cooperation with national and international agencies, giving you a complete guide to a full anti-counterfeiting strategy.
